Package 71335-0881-3

{"route": ["ORAL"], "spl_id": "a148ddb8-adb0-46dc-90ed-7df37af2a4ce", "openfda": {"unii": ["976728SY6Z"], "rxcui": ["833528"], "spl_set_id": ["f3e631c5-1204-419c-8dbe-fa9b37a77f97"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "200 TABLET in 1 BOTTLE (71335-0881-1)", "package_ndc": "71335-0881-1", "marketing_start_date": "20211227"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (71335-0881-2)", "package_ndc": "71335-0881-2", "marketing_start_date": "20190103"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (71335-0881-3)", "package_ndc": "71335-0881-3", "marketing_start_date": "20211227"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (71335-0881-4)", "package_ndc": "71335-0881-4", "marketing_start_date": "20180626"}, {"sample": false, "description": "10 TABLET in 1 BOTTLE (71335-0881-5)", "package_ndc": "71335-0881-5", "marketing_start_date": "20211227"}], "brand_name": "Amiodarone Hydrochloride", "product_id": "71335-0881_a148ddb8-adb0-46dc-90ed-7df37af2a4ce", "dosage_form": "TABLET", "pharm_class": ["Antiarrhythmic [EPC]", "Cytochrome P450 1A2 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "71335-0881", "generic_name": "Amiodarone Hydrochloride", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amiodarone Hydrochloride", "active_ingredients": [{"name": "AMIODARONE HYDROCHLORIDE", "strength": "200 mg/1"}], "application_number": "ANDA075424", "marketing_category": "ANDA", "marketing_start_date": "20010330", "listing_expiration_date": "20261231"}